Background: Many single nucleotide polymorphisms (SNPs) influence prostate cancer (PCa)
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Introduction
The predisposition to prostate cancer (PCa) is multifactorial with important contributions from genetic and environmental factors. Recent studies have identified numerous low penetrance single nucleotide polymorphisms (SNPs) accounting for a proportion of PCa susceptibility(1-3). Zheng et al. reported that prostate cancer risk increased with cumulative number of risk genotypes for 5 SNPs, and that when family history was additionally considered, men who had 5 or 6 risk factors -risk genotypes and/or family history -had a 9-fold increased prostate cancer risk compared to men with no risk genotypes and a negative family history. (4) Additionally, a Swedish study that combined PCa risk alleles into a genetic risk score found that it predicted PCa on biopsy among men with low PSA levels (1-3 ng/mL). (5) Numerous environmental factors have also been investigated in association with PCa risk, including diet, exercise, and medications (6) (7) (8) . The relative contribution of genes and environment to prostate carcinogenesis remains uncertain. A Scandinavian twin study suggested an overall heritability index of 42%,(9) indicating a major contribution also from environmental factors. Migration studies have shown that immigrants from low to high-risk countries experience higher PCa rates, further supporting that environmental factors are important. (10) Although genetic screening tests for diseases, including PCa, are now commercially available to consumers,(11) these tests are controversial because they have not been shown to improve clinical outcomes, as demonstrated by the conflict between the FDA and the personal genomic testing company 23andme.(12) Further, no guidance is available on how the 5 5 information from these tests can be used by patients and clinicians in healthcare decisionmaking. (13) For example, if a man is found to be at higher genetic risk for PCa, is there anything he can do to reduce his risk? At present, the answer to this question is unknown. Thus, the purpose of our study was to evaluate whether environmental factors, such as diet and lifestyle, modify the association between 20 validated PCa susceptibility SNPs, previously identified including in genomewide association studies (GWAS), and the risk of PCa overall, and by stage and grade. 6 
Materials and Methods
We performed an analysis of existing data from a GWAS performed in a case-control study nested in the screening arm of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. These data are available in the Cancer Genetic Markers of Susceptibility (CGEMS) database (http://cgems.cancer.gov) (1), and we accessed them under a confidentiality agreement. The PLCO included men ages 55-74 years at baseline recruited at 10 U.S.
centers. (14) For six years, men in the PCa-screening arm underwent yearly prostate-specific antigen (PSA) tests and digital-rectal examinations (DRE). The trial investigators referred men with a PSA >4 ng/mL or suspicious DRE to their medical providers for further evaluation. All participants provided informed consent, and the institutional review boards at all participating institutions approved the trial.
We included in this analysis 1,230 incident PCa cases and 1,361 controls who were nonHispanic white and were frequency-matched on age in 5-year intervals. PCa status was ascertained using the National Death Index and annual health history questionnaires, with confirmation and additional details on stage and grade obtained from review of the medical records. Nonadvanced stage cases were defined as clinical stage I and II tumors. Advanced cases were defined as clinical stage III and IV (regional or distant). Gleason score was divided into low (Gleason ≤6), intermediate (Gleason 7), and high (Gleason ≥8) grade.
The participants completed a baseline questionnaire including demographics, education, past medical history, medications, smoking history, height, weight, and physical activity.
Participants also completed a 137-item food frequency questionnaire to assess dietary patterns adding intakes from diet and supplements. From these questionnaires, we selected environmental factors that are modifiable with the greatest consensus for further evaluation because they are purported risk or protective factors for PCa or other major cancers. (6, 7, 17) The factors we selected were: body mass index (BMI; at age 20, age 50, baseline); vigorous physical activity; smoking; alcohol drinking; aspirin use, ibuprofen use; intake of fruit, vegetables, broccoli, red meat (total, ruminants only), energy, fat, vitamin D, zinc, folate, and lycopene; use of a multivitamin (current, within the last 2 years), selenium supplement, vitamin E supplement; and high intake of calcium (primarily from supplement use).
The participants also provided a blood sample at baseline and/or subsequent screening years. DNA extracted from buffy coat was used for the prior GWAS study in the PLCO (1). We identified 20 SNPs previously associated with PCa susceptibility and validated from the literature (Supplementary Table 1 ) (1, 4, (18) (19) (20) (21) (22) (23) (24) and that had already been genotyped in the PLCO GWAS. Using the existing data, we calculated a genetic risk score for each man based on the number of risk alleles for the 20 SNPs. We defined a higher genetic risk score as carrying ≥12 risk alleles, the median number (and mode) in controls. No obvious threshold in the OR was present across number of risk alleles (see Results), thus we dichotomized at the median number of risk alleles to have roughly equal information in the two groups (under the null hypothesis). We used logistic regression to evaluate the association between higher genetic risk score and the risk of total PCa as well as disease that was nonadvanced or advanced stage; low into the model (adjusting for age and education) terms for higher genetic risk score, the environmental factor, and their cross-product, the coefficient for which we evaluated using the Wald test. For nominally statistically significant interactions (P<0.05), we further explored the nature of the multiplicative interaction by modeling joint associations. For the most robust interaction, we also evaluated the joint association across number of risk alleles using the mode (12 risk alleles) in the unexposed as the reference group. All tests were 2-sided and analyses were conducted using SAS v.9.3 (Cary, NC). Effect modification (P-interaction<0.05) of the association between higher genetic risk score (≥12 risk alleles) and PCa risk was observed for aspirin use, ibuprofen use, vegetable intake and selenium supplement use (Table 2 and Supplemental Table 2 ). Selenium supplement use was the only environmental factor that we evaluated that statistically significantly modified the higher genetic risk of advanced stage disease: among nonusers of selenium supplements, higher genetic risk score was more strongly associated with risk of total (P-interaction=0.033) and advanced stage (P-interaction=0.031) PCa, whereas in users of selenium supplements these 10 associations were all null. Aspirin and ibuprofen use, and vegetable intake modified the risk of nonadvanced stage and low grade disease only. Among men who did not use aspirin, we observed a stronger association between higher genetic risk and total (P-interaction=0.028), nonadvanced stage (P-interaction=0.009), and low grade (P-interaction=0.0008) PCa, whereas these associations were attenuated among men who used aspirin ( Table 2 and Supplemental Table 2 ). Among men who did not use ibuprofen, we observed a stronger association between higher genetic risk and nonadvanced stage (P-interaction=0.023), and low grade (Pinteraction=0.008) disease; whereas these associations were attenuated in ibuprofen users (Table 2 and Supplemental Table 2 ). Among men with low vegetable intake (lowest tertile), higher genetic risk was more strongly associated with risk of nonadvanced stage (Pinteraction=0.010) and low grade (P-interaction=0.014) disease, whereas in men who consumed more vegetables (middle and highest tertiles), these associations were attenuated.
Results
Possible effect modification was observed by intake of fruit, vegetables, folate, and lycopene (Table 2 and Supplemental Table 2 ), but the interactions were less robust (0.05<P-interaction ≤0.15) and patterns were not as clear or were inconsistent across strata of the effect modifier or PCa features. Possible effect modification was present by BMI at age 20 years (Table 2 and   Supplemental Table 2 ). However, the interactions were not statistically significant and the association for higher genetic risk score was reduced in men who were overweight and obese at age 20 years (nonadvanced stage PCa: overweight/obese -OR=1.50, 95% CI 0.94-2.37, normal -OR=2.09, 95% CI 1.62-2.68; P-interaction=0.28; advanced stage PCa: 11 overweight/obese -OR=1.82, 95% CI 1.19-2.78, normal -OR=2.13, 95% CI 1.69-2.70; Pinteraction=0.61), which would not be an appropriate preventive strategy.
We next evaluated the joint associations for higher genetic risk score and use of a selenium supplement, aspirin, ibuprofen, and vegetable intake with advanced or nonadvanced stage PCa (Table 3) . Men with ≥12 risk alleles and who used a selenium supplement had a similar risk to men with <12 risk alleles and who did not use a selenium supplement. In contrast, among men with <12 risk alleles, those who used a selenium supplement appeared to have an increased risk of advanced stage disease, although this association was not statistically significant (Table 3 ). Among men with <12 risk alleles, using aspirin or ibuprofen or eating more vegetables did not appear to attenuate the genetic risk of nonadvanced stage disease.
However, among men with ≥12 risk alleles, the genetic risk of nonadvanced disease was attenuated with aspirin or ibuprofen use and eating more vegetables. Despite this attenuation, the risk of nonadvanced stage disease was still ~70% higher than in men with <12 risk alleles who did not use aspirin or ibuprofen and ate fewer vegetables.
Finally, we evaluated the pattern of effect modification for aspirin and selenium across the range of genetic risk scores using 12 risk alleles in the unexposed as the reference. Figure 1 shows joint associations for categories of number of risk alleles and aspirin use: the increased risk of nonadvanced stage PCa associated with carrying 13 risk alleles or ≥14 risk alleles was attenuated in aspirin users; however, the association between carrying ≤9 risk alleles and nonadvanced disease was less inverse among aspirin users. The increased risk of advanced stage disease associated with carrying ≥13 risk alleles appeared to be attenuated in selenium 
Discussion
In this prospective study evaluating 20 SNPs that were previously associated with PCa susceptibility, we observed that selenium supplement use may reduce the genetic risk of advanced stage PCa and that aspirin and ibuprofen use and vegetable intake may reduce the genetic risk of nonadvanced stage and low grade PCa. While based on data from one cohort only, our results may help inform the testing of strategies for prevention among those at higher genetic risk.
To date, only a few preventive interventions have been evaluated in a randomized, prospective fashion. 5-alpha reductase inhibitors (5ARI's) were shown to decrease the incidence of biopsy-detectable PCa. (25, 26) However, they lead to sexual side effects and their use for PCa prevention was rejected by the FDA due to an absolute increase in the incidence of high-grade PCa. (27) Epidemiologic studies have also suggested a protective relationship between many other modifiable factors with PCa risk, but they have not been validated or cannot be practically tested in randomized trials.(6) Moreover, relatively little research has been conducted on gene-environment interactions and PCa risk. Thus, the goal of our study was to specifically evaluate whether environmental factors that men have some control over may reduce or eliminate the genetic risk of PCa, especially aggressive disease.
Among men with a high genetic risk profile, we found that selenium supplement use may attenuate the risk of advanced stage disease, while aspirin, ibuprofen and higher vegetable intake may attenuate the risk of nonadvanced stage disease. Some studies support that higher selenium intake, especially from a supplement, may reduce PCa risk, (28) 
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Nutritional Prevention of Cancer (NPC) Study. In that study, the reduction in risk association with selenium supplementation was limited to men with low circulating selenium levels at baseline. (29) In a nested case-control study in the PLCO, the same cohort in which the current study was done, no statistically significant association between serum selenium levels and the incidence of total or advanced PCa was found, although higher serum levels were inversely associated with PCa in smokers and men with highest total intake of Vitamin E. (16) However, our results suggest that the risk to benefit ratio may shift for men with a higher genetic risk profile.
Finally, we found that higher vegetable intake may also modify the higher genetic risk of nonaggressive PCa. Aside from tomatoes and possibly broccoli, there is limited evidence that vegetable intake protects against PCa risk.(6, 34, 35) In the PLCO, intake of broccoli and other cruciferous vegetables was associated with a lower risk of aggressive PCa.(36) The benefits of vegetable consumption are numerous for good health in general, so while it is possible that some men could benefit from vegetable intake more than others with respect to PCa, promoting vegetable consumption by all men irrespective of genetic risk is sound public health advice.
A strength of this study is the robust dataset, including environmental factors and genotypes, allowing a comprehensive examination of their interactions. The findings from our study have importance as we move toward an era of personalized medicine, and for the design of future intervention studies. Another strength of the study is that food frequency questionnaires were administered at baseline, eliminating the possibility of biased recall following PCa diagnosis. All participants were subjected to a uniform screening protocol within Nevertheless, even a reduction in the detectability of nonaggressive cancers could represent an important public health benefit, given current concerns with overdiagnosis and overtreatment.
Another important limitation is that our study only included non-Hispanic white male participants from the PLCO screening trial, and therefore it is unclear whether the findings are PLCO (the data used in the current analysis).(2) Also, our study focused on a limited number of pre-selected possible effect modifiers assessed by questionnaire. As such, future studies are necessary to further examine many other potential gene-environment interactions outside the scope of the current study. Finally, the results of this study are observational in nature, and therefore it is not possible to determine whether modification of these environmental exposures would ultimately decrease the risk of PCa development or detection.
In conclusion, since personalized genomic testing is now available, there is an urgent need for further study on gene-environment interactions and the identification and testing of preventive strategies for men at higher genetic risk for PCa. Our results from this prospective study nested in the PLCO suggests that selenium supplement use may reduce the genetic risk of advanced stage PCa and that aspirin, ibuprofen, and vegetable intake may attenuate the genetic risk of nonadvanced stage and low grade PCa. Table 2 
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